Harmony licenses US rights to Bioprojet's pitolisant
Harmony Biosciences LLC licensed exclusive US development and marketing rights to Bioprojet's pitolisant (BF2649, also known as tiprolisant) for narcolepsy.
- Drug Discovery Tools
- Includes Contract
- Includes Royalty or Profit Split Information
- Intra-Biotech Deal
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com